297 related articles for article (PubMed ID: 19605771)
1. Chronic daily headache in adolescents: an 8-year follow-up study.
Wang SJ; Fuh JL; Lu SR
Neurology; 2009 Aug; 73(6):416-22. PubMed ID: 19605771
[TBL] [Abstract][Full Text] [Related]
2. Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study.
Wang SJ; Fuh JL; Lu SR; Juang KD
Neurology; 2007 Feb; 68(8):591-6. PubMed ID: 17182975
[TBL] [Abstract][Full Text] [Related]
3. Chronic daily headache in adolescents: prevalence, impact, and medication overuse.
Wang SJ; Fuh JL; Lu SR; Juang KD
Neurology; 2006 Jan; 66(2):193-7. PubMed ID: 16434652
[TBL] [Abstract][Full Text] [Related]
4. A 13-year long-term outcome study of elderly with chronic daily headache.
Fuh JL; Wang SJ; Lu SR; Tsai PH; Lai TH; Lai KL
Cephalalgia; 2008 Oct; 28(10):1017-22. PubMed ID: 18624806
[TBL] [Abstract][Full Text] [Related]
5. Migraine days decline with duration of illness in adolescents with transformed migraine.
Bigal ME; Sheftell FD; Tepper SJ; Rapoport AM; Lipton RB
Cephalalgia; 2005 Jul; 25(7):482-7. PubMed ID: 15955034
[TBL] [Abstract][Full Text] [Related]
6. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
[TBL] [Abstract][Full Text] [Related]
7. [Management of chronic daily headache in children and adolescents].
Cuvellier JC
Rev Neurol (Paris); 2009; 165(6-7):521-31. PubMed ID: 19041108
[TBL] [Abstract][Full Text] [Related]
8. Chronic migraine with medication overuse: treatment outcome and disability at 3 years follow-up.
Usai S; Grazzi L; Andrasik F; D'Amico D; Rigamonti A; Bussone G
Neurol Sci; 2004 Oct; 25 Suppl 3():S272-3. PubMed ID: 15549557
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors of chronic daily headache in young adolescents: a school cohort study.
Lu SR; Fuh JL; Wang SJ; Juang KD; Chen SP; Liao YC; Wang YF
Pediatrics; 2013 Jul; 132(1):e9-e16. PubMed ID: 23776112
[TBL] [Abstract][Full Text] [Related]
10. The classification of chronic daily headache in adolescents--a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria.
Bigal ME; Rapoport AM; Tepper SJ; Sheftell FD; Lipton RB
Headache; 2005 May; 45(5):582-9. PubMed ID: 15953277
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
12. Duration of migraine is a predictor for response to botulinum toxin type A.
Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
[TBL] [Abstract][Full Text] [Related]
13. Chronic daily headache in children and adolescents: a clinic based study from India.
Chakravarty A
Cephalalgia; 2005 Oct; 25(10):795-800. PubMed ID: 16162256
[TBL] [Abstract][Full Text] [Related]
14. Major life changes before and after the onset of chronic daily headache: a population-based study.
Scher AI; Stewart WF; Buse D; Krantz DS; Lipton RB
Cephalalgia; 2008 Aug; 28(8):868-76. PubMed ID: 18557980
[TBL] [Abstract][Full Text] [Related]
15. Chronic daily headache in childhood and adolescence: clinical aspects and a 4-year follow-up.
Galli F; Patron L; Russo PM; Bruni O; Ferini-Strambi L; Guidetti V
Cephalalgia; 2004 Oct; 24(10):850-8. PubMed ID: 15377316
[TBL] [Abstract][Full Text] [Related]
16. Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up.
Grazzi L; Andrasik F; D'Amico D; Usai S; Kass S; Bussone G
Headache; 2004; 44(7):678-83. PubMed ID: 15209690
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of migraine and tension-type headache: a population-based follow-up study.
Lyngberg AC; Rasmussen BK; Jørgensen T; Jensen R
Neurology; 2005 Aug; 65(4):580-5. PubMed ID: 16116119
[TBL] [Abstract][Full Text] [Related]
19. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
Mathew NT; Kailasam J; Meadors L
Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
[TBL] [Abstract][Full Text] [Related]
20. Head or neck injury increases the risk of chronic daily headache: a population-based study.
Couch JR; Lipton RB; Stewart WF; Scher AI
Neurology; 2007 Sep; 69(11):1169-77. PubMed ID: 17846416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
